• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NAGAOKA KATSUYA  長岡 克弥

… Alternative Names

Nagaoka Katsuya  長岡 克弥

Less
Researcher Number 00759524
Other IDs
  • ORCIDhttps://orcid.org/0000-0002-7152-6101
Affiliation (Current) 2025: 熊本大学, 病院, 助教
Affiliation (based on the past Project Information) *help 2020 – 2023: 熊本大学, 病院, 助教
2019: 熊本大学, 病院, 特任助教
2018: 熊本大学, 医学部附属病院, 医員
2016: 熊本大学, 医学部附属病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 53010:Gastroenterology-related
Except Principal Investigator
Basic Section 53010:Gastroenterology-related / Medium-sized Section 50:Oncology and related fields / Gastroenterology
Keywords
Principal Investigator
補酵素 / エネルギー代謝 / 化学療法抵抗性 / 膵癌 / 胆道癌 / 血液バイオマーカー / アスパラギン酸-β-ヒドロキシラーゼ / DNA損傷 / 胆管癌 / 2-オキソグルタル酸 … More / 細胞環境 / 肝発癌 / 治療抵抗性 / 合成致死性 / HDAC阻害薬 / 転写因子 / 脂質代謝 / SIRT阻害薬 / 治療耐性獲得機構 / 治療抵抗性獲得機序 / 分子標的治療薬 / エピゲノム薬 / 肝癌 … More
Except Principal Investigator
代謝リプログラミング / マルチオミクス解析 / エピゲノム / エピジェネテイクス / 治療抵抗性 / 肝癌 / エピゲノム制御薬 / マイクロRNA / 肝発癌進展 / NASH / 脂質代謝 / 肝癌細胞 / 栄養環境 / LSD2 / STC2 / 脂肪肝 / 小胞体ストレス / 酸化ストレス / 栄養・代謝環境 / エピゲノム制御 / メダボローム解析 / メタボローム / 肝発癌 / メタボローム解析 / 転写因子 / ヒストン脱メチル化酵素 / 原発性肝癌 / オミクス解析 / 効果予測マーカー / 分子標的治療薬 / 細胞環境 / 乳酸アシドーシス / 高血糖 / 代謝 / 遺伝子 / 胆管細胞癌 / プロテオミクス / 遺伝子解析 / 燐酸化 / 内科 / 癌 / マルチオミクス / バイオインフォマテイクス / 細胞死抵抗性 / 翻訳後修飾 / プロテオミクス / 微小環境 Less
  • Research Projects

    (6 results)
  • Research Products

    (84 results)
  • Co-Researchers

    (15 People)
  •  Elucidation of the resistance mechanism to chemotherapy in biliary tract and pancreatic cancer by focusing on energy-metabolizing coenzymesPrincipal Investigator

    • Principal Investigator
      長岡 克弥
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Kumamoto University
  •  Elucidation of nutrition-induced epigenetic changes in hepatocytes and their application to the regulation of hepatocellular carcinoma development and progression.

    • Principal Investigator
      SASAKI Yutaka
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Kumamoto University
      Nagasaki International University
  •  Analysis of epigenome and metabolic phenotypes in Thai liver fluke-associated cholangiocarcinoma

    • Principal Investigator
      NAKAO MITSUYOSHI
    • Project Period (FY)
      2020 – 2023
    • Research Category
      Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
    • Review Section
      Medium-sized Section 50:Oncology and related fields
    • Research Institution
      Kumamoto University
  •  Basic research and Clinical Application of Hepatocellular Carcinoma Therapy by Interaction of Epigenetic Drugs and Environmental FactorsPrincipal Investigator

    • Principal Investigator
      Nagaoka Katsuya
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Kumamoto University
  •  Analysis of metabolic reprogramming induced by cellular environment and its application to control hepato-carcinogenesis

    • Principal Investigator
      SASAKI YUTAKA
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Kumamoto University
  •  Analysis of microenvironment-mediated treatment resistance of hepatocellular carcinoma in terms of integrated proteomics

    • Principal Investigator
      Sasaki Yutaka
    • Project Period (FY)
      2013 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Gastroenterology
    • Research Institution
      Kumamoto University

All 2024 2023 2022 2021 2020 2019 2018 2016 2015

All Journal Article Presentation Book

  • [Book] 薬剤性消化器疾患の治療 (3) 肝臓 『臨牀消化器内科 Vol.35 No.7(3-3)』2020

    • Author(s)
      長岡 克弥 , 德永 尭之 , 田中 基彦
    • Total Pages
      8
    • Publisher
      株式会社日本メディカルセンター
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Book] (薬剤性消化器疾患の治療(3)肝臓)薬剤性消化器疾患の治療2020

    • Author(s)
      長岡克弥、徳永尭之、田中基彦
    • Total Pages
      8
    • Publisher
      株式会社日本メディカルセンター
    • ISBN
      9784524263318
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Journal Article] Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents2024

    • Author(s)
      Suzuki Takanori、Matsuura Kentaro、Nagura Yoshihito、Kawamura Hayato、Fujiwara Kei、Ogawa Shintaro、Nagaoka Katsuya、Iio Etsuko、Watanabe Takehisa、Kataoka Hiromi、Tanaka Yasuhito
    • Journal Title

      Oncology

      Volume: - Issue: 7 Pages: 1-10

    • DOI

      10.1159/000536154

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-20K08314, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-23K27589
  • [Journal Article] A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA2024

    • Author(s)
      Watanabe Takehisa、Hayashi Sanae、Zhaoyu Yan、Inada Hiroki、Nagaoka Katsuya、Tateyama Masakuni、Tanaka Yasuhito
    • Journal Title

      Journal of Gastroenterology

      Volume: 59 Issue: 4 Pages: 315-328

    • DOI

      10.1007/s00535-023-02070-y

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-22K16023, KAKENHI-PROJECT-23K07442, KAKENHI-PROJECT-21K07904
  • [Journal Article] Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase2024

    • Author(s)
      Nagaoka Katsuya、Bai Xuewei、Liu Dan、Cao Kevin、Mulla Joud、Ji Chengcheng、Chen Hongze、Nisar Muhammad Azhar、Bay Amalia、Mueller William、Hildebrand Grace、Gao Jin-Song、Lu Shaolei、Setoyama Hiroko、Tanaka Yasuhito、Wands Jack R.、Huang Chiung-Kuei
    • Journal Title

      Cancer Letters

      Volume: 580 Pages: 216493-216493

    • DOI

      10.1016/j.canlet.2023.216493

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K15953, KAKENHI-PROJECT-23K27589
  • [Journal Article] Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence2024

    • Author(s)
      Qin XY, Shirakami Y, Honda M, Yeh SH, Numata K, Lai YY, Li CL, Wei F, Xu Y, Imai K, Takai K, Chuma M, Komatsu N, Furutani Y, Gailhouste L, Aikata H, Chayama K, Enomoto M, Tateishi R, Kawaguchi K, Yamashita T, Kaneko S, Nagaoka K, Tanaka M, Sasaki Y, Tanaka Y, Baba H, Miura K, Ochi S, Masaki T, et al
    • Journal Title

      International Journal of Cancer

      Volume: - Issue: 3 Pages: 582-594

    • DOI

      10.1002/ijc.34893

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K08342, KAKENHI-PROJECT-21K07892, KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-20K07349, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K07940
  • [Journal Article] Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis2023

    • Author(s)
      Suzuki Takanori、Kimura Yoshihide、Kusakabe Atsunori、Narahara Satoshi、Tokunaga Takayuki、Nagaoka Katsuya、Kuroyanagi Keita、Kawamura Hayato、Kuno Kayoko、Fujiwara Kei、Nojiri Shunsuke、Kataoka Hiromi、Tanaka Yasuhito
    • Journal Title

      Cancer Medicine

      Volume: 13 Issue: 1 Pages: 1-11

    • DOI

      10.1002/cam4.6876

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-23K15076, KAKENHI-PROJECT-21K20906, KAKENHI-PROJECT-23K07359, KAKENHI-PROJECT-23K27589
  • [Journal Article] MEFV mutation is possibly associated with intestinal phenotype of Bechet disease2023

    • Author(s)
      FurutaY, Gushima R, Naoe H, Fujimoto N, Honda M, Hirata S, Miyagawa E, Sakatan K, Mizuhashi Y, Iwakura M, Murai Y, Matsuoka M, Komohara Y, Tanaka Y
    • Journal Title

      Journal of Clinical Medicine

      Volume: 12 Issue: 9 Pages: 3131-3131

    • DOI

      10.3390/jcm12093131

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K08009, KAKENHI-PROJECT-20K16961, KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-22K08546
  • [Journal Article] Wavelength dependence of ultraviolet light inactivation for SARS-CoV-2 omicron variants2023

    • Author(s)
      Fujimoto Nahoko、Nagaoka Katsuya、Tatsuno Ichiro、Oishi Hisashi、Tomita Makoto、Hasegawa Tadao、Tanaka Yasuhito、Matsumoto Takahiro
    • Journal Title

      Scientific Reports

      Volume: 13 Issue: 1 Pages: 9706-9706

    • DOI

      10.1038/s41598-023-36610-6

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-22K08605
  • [Journal Article] Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma2023

    • Author(s)
      Tokunaga Takayuki、Tateyama Masakuni、Kondo Yasuteru、Miuma Satoshi、Miyase Shiho、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Setoyama Hiroko、Fukubayashi Kotaro、Tanaka Motohiko、Tanaka Yasuhito
    • Journal Title

      Cancers

      Volume: 15 Issue: 5 Pages: 1568-1568

    • DOI

      10.3390/cancers15051568

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K15953, KAKENHI-PROJECT-21K07904
  • [Journal Article] Serum inducible protein 10?kDa/C‐X‐C motif chemokine?10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis?C virus eradication by direct‐acting antiviral agents2023

    • Author(s)
      Nagura Yoshihito、Suzuki Takanori、Matsuura Kentaro、Ogawa Shintaro、Kawamura Hayato、Kuno Kayoko、Fujiwara Kei、Nojiri Shunsuke、Nagaoka Katsuya、Iio Etsuko、Watanabe Takehisa、Kataoka Hiromi、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: 54 Issue: 1 Pages: 32-42

    • DOI

      10.1111/hepr.13962

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-19K08427, KAKENHI-PROJECT-20K08314, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-23K27589
  • [Journal Article] Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation2023

    • Author(s)
      Kugiyama Naotaka、Hashigo Shunpei、Nagaoka Katsuya、Watanabe Takehisa、Ushijima Shinya、Uramoto Yukiko、Yoshinari Motohiro、Morinaga Jun、Gushima Ryosuke、Tateyama Masakuni、Tanaka Motohiko、Naoe Hideaki、Sugawara Yasuhiko、Hibi Taizo、Tanaka Yasuhito
    • Journal Title

      DEN Open

      Volume: 4 Issue: 1

    • DOI

      10.1002/deo2.305

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K08009
  • [Journal Article] Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma2023

    • Author(s)
      Yoshimaru Yoko、Nagaoka Katsuya、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Tokunaga Takayuki、Iio Etsuko、Watanabe Takehisa、Setoyama Hiroko、Tateyama Masakuni、Yoshida Koji、Tsunoda Takuya、Nakamura Yusuke、Tanaka Motohiko、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: - Issue: 5 Pages: 451-464

    • DOI

      10.1111/hepr.13995

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-22K16023, KAKENHI-PROJECT-23K15076, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K15953, KAKENHI-PROJECT-23K27589
  • [Journal Article] Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity.2022

    • Author(s)
      Tokunaga T, Nagaoka K, Watanabe T, Tanaka M, Tanaka Y, et al.
    • Journal Title

      Hepatol Res

      Volume: 52 Issue: 1 Pages: 105-119

    • DOI

      10.1111/hepr.13720

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K15953
  • [Journal Article] Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation2022

    • Author(s)
      Hino Yuko、Nagaoka Katsuya、Oki Shinya、Etoh Kan、Hino Shinjiro、Nakao Mitsuyoshi
    • Journal Title

      Nucleic Acids Research

      Volume: 50 Issue: 17 Pages: 9765-9779

    • DOI

      10.1093/nar/gkac735

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K19513, KAKENHI-PROJECT-22K15971, KAKENHI-PROJECT-20KK0185, KAKENHI-PROJECT-20H04108, KAKENHI-PROJECT-21H02686, KAKENHI-PROJECT-20K16145
  • [Journal Article] Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation2021

    • Author(s)
      Arima Yuichiro、Nakagawa Yoshiko、Takeo Toru、Ishida Toshifumi、Yamada Toshihiro、et al.
    • Journal Title

      Nature Metabolism

      Volume: 3 Issue: 2 Pages: 196-210

    • DOI

      10.1038/s42255-021-00342-6

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K08110, KAKENHI-PROJECT-19K08520, KAKENHI-PROJECT-19H03711, KAKENHI-PROJECT-20H04108, KAKENHI-PROJECT-18K06817, KAKENHI-PROJECT-19K22639, KAKENHI-PROJECT-19K16111, KAKENHI-PROJECT-16H06276, KAKENHI-PROJECT-19K09008, KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-19H04446, KAKENHI-PROJECT-21H02686, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K19519, KAKENHI-PROJECT-20KK0185, KAKENHI-PROJECT-18H02798, KAKENHI-PROJECT-19H01048
  • [Journal Article] Ten‐Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild‐Type Isocitrate Dehydrogenase 12021

    • Author(s)
      Bai Xuewei、Zhang Hongyu、Zhou Yamei、Nagaoka Katsuya、Meng Jialin、Ji Chengcheng、Liu Dan、Dong Xianghui、Cao Kevin、Mulla Joud、Cheng Zhixiang、Mueller William、Bay Amalia、Hildebrand Grace、Lu Shaolei、Wallace Joselynn、Wands Jack R.、Sun Bei、Huang Chiung‐Kuei
    • Journal Title

      Hepatology

      Volume: 73 Issue: 5 Pages: 1747-1763

    • DOI

      10.1002/hep.31486

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-18H02798
  • [Journal Article] Mac‐2 binding protein and its glycan isomer: Where does it come from? Where is it going?2021

    • Author(s)
      Nagaoka Katsuya、Tanaka Motohiko、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: 51 Issue: 10 Pages: 1026-1028

    • DOI

      10.1111/hepr.13697

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Journal Article] Modified albumin?bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients2021

    • Author(s)
      Tokunaga Takayuki、Tanaka Motohiko、Tanaka Kentaro、Narahara Satoshi、Kawasaki Takeshi、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Tateyama Masakuni、Naoe Hideaki、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 5 Pages: 922-932

    • DOI

      10.1007/s10147-020-01835-2

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-18K07945, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-18H02798
  • [Journal Article] Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins2021

    • Author(s)
      Hayashi Sanae、Nagaoka Katsuya、Tanaka Yasuhito
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 20 Pages: 11051-11051

    • DOI

      10.3390/ijms222011051

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-20K16996
  • [Journal Article] Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma2021

    • Author(s)
      Narahara S, Watanabe T, Nagaoka K, Fujimoto N, Furuta Y, Tanaka K, Tokunaga T, Kawasaki T, Yoshimaru Y, Setoyama H, Oniki K, Saruwatari J, Tateyama M, Naoe H, Tanaka M, Tanaka Y, Sasaki Y.
    • Journal Title

      Hepatology Communications

      Volume: - Issue: 5 Pages: 1198-1212

    • DOI

      10.1002/hep4.1872

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K07166, KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-20K07134, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K15953
  • [Journal Article] Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis2020

    • Author(s)
      Nagaoka Katsuya、Ogawa Kousuke、Ji Chengcheng、Cao Kevin Y.、Bai Xuewei、Mulla Joud、Cheng Zhixiang、Wands Jack R.、Huang Chiung-Kuei
    • Journal Title

      Digestive Diseases and Sciences

      Volume: 66 Issue: 4 Pages: 1080-1089

    • DOI

      10.1007/s10620-020-06330-2

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-18H02798
  • [Journal Article] Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study2020

    • Author(s)
      Tateyama Masakuni、Naoe Hideaki、Tanaka Motohiko、Tanaka Kentaro、Narahara Satoshi、Tokunaga Takayuki、Kawasaki Takeshi、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Setoyama Hiroko、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      BMC Gastroenterology

      Volume: 20 Issue: 1 Pages: 371-371

    • DOI

      10.1186/s12876-020-01501-x

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-18H02798
  • [Journal Article] The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism2020

    • Author(s)
      Nagaoka K. Mulla J, Huang, CK, et al.
    • Journal Title

      Liver Research

      Volume: 4 Pages: 94-100

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Journal Article] The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism2020

    • Author(s)
      Nagaoka Katsuya、Mulla Joud、Cao Kevin、Cheng Zhixiang、Liu Dan、William Mueller、Bay Amalia、Hildebrand Grace、Lu Shaolei、Huang Chiung-Kuei
    • Journal Title

      Liver Research

      Volume: 4 Issue: 2 Pages: 94-100

    • DOI

      10.1016/j.livres.2020.04.001

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Journal Article] Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation2019

    • Author(s)
      Takase Ryuta、Hino Shinjiro、Nagaoka Katsuya、Anan Kotaro、Kohrogi Kensaku、Araki Hirotaka、Hino Yuko、Sakamoto Akihisa、Nicholson Thomas B.、Chen Taiping、Nakao Mitsuyoshi
    • Journal Title

      The FASEB Journal

      Volume: 33 Issue: 4 Pages: 5300-5311

    • DOI

      10.1096/fj.201801422rr

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K19479, KAKENHI-PROJECT-16K07215, KAKENHI-PROJECT-19K17403, KAKENHI-PROJECT-18H02618
  • [Journal Article] 肝エネルギー代謝とエピゲノム解析のマルチオミクス解析2016

    • Author(s)
      長岡克弥、佐々木裕
    • Journal Title

      肝胆膵

      Volume: 73 Pages: 719-724

    • Data Source
      KAKENHI-PROJECT-25293173
  • [Journal Article] Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells2015

    • Author(s)
      Nagaoka K, Hino S, Sakamoto A, Anan K, Takase R, Umehara T, Yokoyama S, Sasaki Y and Nakao M.
    • Journal Title

      Molecular cellular Biology

      Volume: 35(7) Pages: 68-1080

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293173
  • [Journal Article] Lysine-specific demethylase LSD2 suppresses lipid influx and metabolism in hepatic cells.2015

    • Author(s)
      Nagaoka K, Hino S, Sakamoto A, Anan K, Takase R, Umehara T, Yokoyama S, Sasaki Y and Nakao M.
    • Journal Title

      Molecular Cellular Biology

      Volume: in press

    • Data Source
      KAKENHI-PROJECT-25293173
  • [Presentation] TET1-mediated 5-hydroxymethylcytosine is involved in hepatocyte apoptosis in alcoholic liver disease progression.2023

    • Author(s)
      Nagaoka K, Huang C K., Tanaka Y.
    • Organizer
      JSH International Liver Conference, Tokyo.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] A Possible diagnostic marker of mitochondrial dysfunction, AREG, is associated with tumor size in hepatocellular carcinoma.2023

    • Author(s)
      Nagaoka K, Watanabe T, Tanaka Y, et al.
    • Organizer
      APASL Single Topic Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] ミトコンドリア機能不全がもたらすNAFLD肝組織におけるアンフィレグリン発現増加2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第109回日本消化器病学会総会 シンポジウム13
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] INTERFERON-RELATED GENE EXPRESSION CHANGES MEDIATED BY ALPHAFETOPROTEIN IN PATIENTS WHO DEVELOPED HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C VIRUS ERADICATION2023

    • Author(s)
      Nagaoka K, Watanabe T, Tanaka Y, et al.
    • Organizer
      American Association for the Study of Liver Disease, Liver meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] 転写因子・エピゲノム統合解析を用いた肝細胞癌ミトコンドリア機能不全の診断マーカーの同定2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第59回日本肝臓学会総会パネルディスカッション4
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] HCV排除後肝発癌に寄与するミトコンドリア関連遺伝子群の同定2023

    • Author(s)
      長岡克弥, 大西雅也, 田中靖人
    • Organizer
      第27回日本肝臓学会大会 シンポジウム11
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] A Possible diagnostic marker of mitochondrial dysfunction, AREG, is associated with tumor size in hepatocellular carcinoma.2023

    • Author(s)
      Katsuya Nagaoka, Yuko Hino, Satoshi Narahara, Sotaro Kurano, Kentaro Tanaka, Hiroki Inada, Takayuki Tokunaga, Etsuko Iio, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Hideaki Naoe, Hiromitsu Hayashi, Hideo Baba, Shinjiro Hino, Mitsuyoshi Nakao, Yasuhito Tanaka.
    • Organizer
      APASL Single Topic Conference. Sendai, Miyagi.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] INTERFERON-RELATED GENE EXPRESSION CHANGES MEDIATED BY ALPHAFETOPROTEIN IN PATIENTS WHO DEVELOPED HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C VIRUS ERADICATION2023

    • Author(s)
      Katsuya Nagaoka, Masakuni Tateyama, Satoshi Narahara, Sotaro Kurano, Kentaro Tanaka, Hiroki Inada, Takayuki Tokunaga, Etsuko Iio, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Hideaki Naoe, Tanaka Y.
    • Organizer
      American Association for the Study of Liver Disease, Liver meeting 2023, Boston, MA., USA.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] 転写因子・エピゲノム統合解析を用いた肝細胞癌ミトコンドリア機能不全の診断マーカーの同定2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第59回日本肝臓学会総会 パネルディスカッション4
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] TET1-mediated 5-hydroxymethylcytosine is involved in hepatocyte apoptosis in alcoholic liver disease progression.2023

    • Author(s)
      Nagaoka K, Huang C K., Tanaka Y.
    • Organizer
      JSH International Liver Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] ミトコンドリア機能不全がもたらすNAFLD肝組織におけるアンフィレグリン発現増加2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第109回日本消化器病学会総会 シンポジウム13
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] C型慢性肝疾患におけるAFPがもたらす肝発癌の分子機構2022

    • Author(s)
      長岡克弥、立山雅邦、田中靖人
    • Organizer
      第44回日本肝臓学会東部会
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] ミトコンドリアストレスを切り口としたNAFLD病態の解析とアンフィレグリン発現の意義2022

    • Author(s)
      長岡克弥、田中靖人
    • Organizer
      第36回肝類洞壁細胞研究会学術集会
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] エネルギー代謝補酵素に着目した胆道癌化学療法抵抗性機序の検討2022

    • Author(s)
      長岡克弥,ファンチュンクエイ, 田中靖人
    • Organizer
      第108回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] メタボローム・トランスクリプトーム解析による肝癌分子標的治療薬の耐性獲得機構の研究2022

    • Author(s)
      長岡克弥、楢原哲史、稲田浩気、田中健太郎、蔵野宗太郎、徳永尭之、吉丸洋子、渡邊丈久、瀬戸山博子、立山雅邦、直江秀昭、田中靖人.
    • Organizer
      第58回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] ソラフェニブ耐性肝癌細胞におけるエピゲノム薬による耐性克服2022

    • Author(s)
      長岡克弥,楢原哲史,林佐奈衣,稲田浩気,田中健太郎,蔵野宗太郎,徳永尭之,吉丸洋子,渡邊丈久,瀬戸山博子,立山雅邦,直江秀昭,田中靖人
    • Organizer
      第26回日本肝臓学会大会
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] 2-Oxoglutarate Cooperates with Aspartate β-Hydroxylase to Enhance Cholangiocarcinoma Resistance to Chemotherapy by Modulating DNA Damage Response Signaling Pathways2022

    • Author(s)
      Nagaoka K, Huang C-K, Tanaka Y
    • Organizer
      APASL Single Topic Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15971
  • [Presentation] 肝内胆管癌におけるAspartateβ-hydroxylase阻害剤とDNA合成阻害剤による相乗的なDNA損傷と抗腫瘍効果の検討2021

    • Author(s)
      長岡克弥、HuangChiung-Kuei、田中靖人
    • Organizer
      第57回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] ヒストン修飾酵素LSD2による肝脂質代謝制御と栄養環境対応性の発現変化~NAFLDの病態解明を目指して~2021

    • Author(s)
      長岡克弥、渡邊丈久、楢原哲史、田中健太郎、徳永尭之、川崎剛、吉丸洋子、瀬戸山博子、立山雅邦、田中基彦、佐々木裕、田中靖人
    • Organizer
      第25回日本肝臓学会大会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] Elevated 2-oxoglutarate antagonizes chemotherapeutic effects in cholangiocarcinoma by targeting DNA damage response signaling pathways.2021

    • Author(s)
      Katsuya Nagaoka, Chengcheng Ji, Xuewei Bai, Kevin Cao, Joud Mulla, Amalia Bay, William Mueller, Grace Hildebrand, Yasuhito Tanaka, Jack R Wands, Chiung-Kuei Huang
    • Organizer
      The 72nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] ヒストン修飾酵素LSD2による肝脂質代謝制御と栄養環境対応性の発現変化~NAFLDの病態解明を目指して~2021

    • Author(s)
      長岡克弥、渡邊丈久、楢原哲史、田中健太郎、徳永尭之、川崎剛、吉丸洋子、瀬戸山博子、立山雅邦、田中基彦、佐々木裕、田中靖人
    • Organizer
      第25回日本肝臓学会大会
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] Elevated 2-oxoglutarate antagonizes chemotherapeutic effects in cholangiocarcinoma by targeting DNA damage response signaling pathways.2021

    • Author(s)
      Nagaoka K, Chengcheng Ji, Wands JR, et al.
    • Organizer
      The 72nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] 肝内胆管癌におけるAspartateβ-hydroxylase阻害剤とDNA合成阻害剤による相乗的なDNA損傷と抗腫瘍効果の検討2021

    • Author(s)
      長岡克弥、HuangChiung-Kuei、田中靖人
    • Organizer
      第57回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-21K07904
  • [Presentation] 進行肝細胞癌に対する集学的なソラフェニブ治療戦略2020

    • Author(s)
      徳永尭之、田中基彦、田中健太郎、楢原哲史、吉丸洋子、川崎剛、長岡克弥、渡邊丈久、立山雅邦、佐々木裕
    • Organizer
      JDDW 2020(第28回 日本消化器関連学会週間)
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 当院におけるHBV電子カルテスクリーニングシステム導入の有用性の評価2020

    • Author(s)
      渡邊丈久、楢原哲史、田中健太郎、徳永尭之、川崎剛、吉丸洋子、長岡克弥、瀬戸山博子、立山雅邦、田中基彦
    • Organizer
      第24回日本肝臓学会大会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] PROGNOSTIC FACTORS ASSOCIATED WITH SURVIVAL IN HEPATOCELLULAR CARCINOMA PATIENTS PROGRESSED ON LENVATINIB THERAPY, PREMISING SUBSEQUENT CHEMOTHERAPY2020

    • Author(s)
      Takayuki Tokunaga, Motohiko Tanaka, Kentaro Tanaka, Satoshi Narahara, Takeshi Kawasaki, Yoko Yoshimaru, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama, Yasuhito Tanaka
    • Organizer
      Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] C型肝硬変に対するインターフェロンフリー治療の食道胃静脈瘤に関する検討2020

    • Author(s)
      楢原哲史、立山雅邦、田中健太郎、徳永尭之、川崎剛、吉丸洋子、長岡克弥、渡邊丈久、田中基彦、佐々木裕
    • Organizer
      第106回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] Prognostic factors associated with survival in hepatocellular carcinoma patients progressed on lenvatinib therapy, premising subsequent chemotherapy2020

    • Author(s)
      Tokunaga T, Nagaoka K, Watanabe T, Tanaka Y, et al.
    • Organizer
      Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] A novel serum biomarker, Clusterin, and related predictive index scoring could be an early predictor of response to Sorafenib in patients with advanced hepatocellular carcinoma2020

    • Author(s)
      Narahara S, Watanabe T, Nagaoka K, Naoe H, Sasaki Y, Tanaka Y, et al.
    • Organizer
      Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 当院におけるHBV電子カルテスクリーニングシステム導入の有用性の評価2020

    • Author(s)
      渡邊丈久、楢原哲史、田中健太郎、徳永尭之、川崎剛、吉丸洋子、長岡克弥、瀬戸山博子、立山雅邦、田中基彦
    • Organizer
      第24回日本肝臓学会大会
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] A NOVEL SERUM BIOMARKER, CLUSTERIN, AND RELATED PREDICTIVE INDEX SCORING COULD BE AN EARLY PREDICTOR OF RESPONSE TO SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA.2020

    • Author(s)
      Satoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Kentaro Tanaka, Takayuki Tokunaga, Takeshi Kawasaki, Yoko Yoshimaru, Masakuni Tateyama, Hideaki Naoe, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka
    • Organizer
      Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 当科における切除不能肝細胞癌に対するレンバチニブ治療の初期経験2020

    • Author(s)
      田中健太郎、徳永尭之、楢原哲史、川崎剛、長岡克弥、瀬戸山博子、吉丸洋子、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第106回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 切除不能進行肝細胞癌に対するソラフェニブを基軸とした集学的治療戦略2020

    • Author(s)
      徳永尭之、田中健太郎、楢原哲史、長岡克弥、吉丸洋子、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第106回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] OPTIMAL STRATEGY OF SWITCHING FROM TRANSARTERIAL CHEMOEMBOLIZATION TO MOLECULAR TARGETED THERAPY FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA2019

    • Author(s)
      Takayuki Tokunaga, Motohiko Tanaka, Kentaro Tanaka, Satoshi Narahara, Yoko Yoshimaru, Tekeshi Kawasaki, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama and Yutaka Sasaki
    • Organizer
      THE LIVER MEETING 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 肝細胞癌に対する肝動脈化学塞栓術から分子標的治療への適切な切り替えタイミングの検討2019

    • Author(s)
      徳永尭之、田中健太郎、楢原哲史、吉丸洋子、川崎剛、長岡克弥、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第55回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 切除不能進行肝細胞癌に対するソラフェニブを基軸とした集学的治療戦略2019

    • Author(s)
      徳永尭之、田中健太郎、楢原哲史、長岡克弥、吉丸洋子、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第105回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] MULTI-OMICS ANALYSES IDENTIFY NUCLEOPHOSMIN AS A KEY REGULATOR OF APOPTOSIS RESISTANCE IN HUMAN HEPATOCELLULAR CARCINOMA2019

    • Author(s)
      Hideaki Naoe, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Norie Araki, Jiro Fujimoto, Motohiko Tanaka and Yutaka Sasaki
    • Organizer
      The Liver Meeting 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] Aspartate β-hydroxylaseを標的とした膵肝癌における抗体薬剤複合体の抗腫瘍効果2019

    • Author(s)
      長岡克弥、佐々木裕
    • Organizer
      第105回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 切除不能進行肝細胞癌に対するソラフェニブを基軸とした集学的治療戦略2019

    • Author(s)
      徳永尭之、田中健太郎、楢原哲史、長岡克弥、吉丸洋子、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第105回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 肝細胞癌に対するソラフェニブの治療効果を早期に予測する新規血清バイオマーカーの解析2019

    • Author(s)
      楢原哲史、渡邊丈久、長岡克弥、田中健太郎、徳永尭之、川崎剛、吉丸洋子、瀬戸山博子、立山雅邦、直江秀昭、田中基彦、佐々木裕
    • Organizer
      第55回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] UPREGULATION OF SECRETORY CLUSTERIN IN RESPONSE TO SORAFENIB LINKS TO ACQUIRED TREATMENT RESISTANCE OF HEPATOCELLULAR CARCINOMA.2019

    • Author(s)
      Satoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Kentaro Tanaka, Takeshi Kawasaki, Yoko Yoshimaru, Masakuni Tateyama, Hideaki Naoe, Motohiko Tanaka and Yutaka Sasaki
    • Organizer
      The Liver Meeting 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 進行肝細胞癌に対する集学的なソラフェニブ治療戦略2019

    • Author(s)
      28.徳永尭之、田中基彦、田中健太郎、楢原哲史、吉丸洋子、川崎剛、長岡克弥、渡邊丈久、立山雅邦、佐々木裕
    • Organizer
      JDDW 2019(第27回 日本消化器関連学会週間)
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 肝細胞癌に対する肝動脈化学塞栓術から分子標的治療への適切な切り替えタイミングの検討2019

    • Author(s)
      徳永尭之、田中健太郎、楢原哲史、吉丸洋子、川崎剛、長岡克弥、渡邊丈久、立山雅邦、田中基彦、佐々木裕
    • Organizer
      第55回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] MULTI-OMICS ANALYSES IDENTIFY NUCLEOPHOSMIN AS A KEY REGULATOR OF APOPTOSIS RESISTANCE IN HUMAN HEPATOCELLULAR CARCINOMA2019

    • Author(s)
      Hideaki Naoe, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Norie Araki, Jiro Fujimoto, Motohiko Tanaka and Yutaka Sasaki
    • Organizer
      THE LIVER MEETING 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] OPTIMAL STRATEGY OF SWITCHING FROM TRANSARTERIAL CHEMOEMBOLIZATION TO MOLECULAR TARGETED THERAPY FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA2019

    • Author(s)
      Takayuki Tokunaga, Motohiko Tanaka, Kentaro Tanaka, Satoshi Narahara, Yoko Yoshimaru, Tekeshi Kawasaki, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama and Yutaka Sasaki
    • Organizer
      The Liver Meeting 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] 肝細胞癌に対するソラフェニブの治療効果を早期に予測する新規血清バイオマーカーの解析2019

    • Author(s)
      楢原哲史、渡邊丈久、長岡克弥、田中健太郎、徳永尭之、川崎剛、吉丸洋子、瀬戸山博子、立山雅邦、直江秀昭、田中基彦、佐々木裕
    • Organizer
      第55回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 胆管癌におけるAspartate-β-hydroxylaseに対する分子標的薬とDNA合成阻害剤の相乗的な抗腫瘍効果2019

    • Author(s)
      長岡克弥、Chiung-Kuei Huang、佐々木裕、Jack R Wands
    • Organizer
      第51回日本臨床分子形態学会総会・学術総会
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] UPREGULATION OF SECRETORY CLUSTERIN IN RESPONSE TO SORAFENIB LINKS TO ACQUIRED TREATMENT RESISTANCE OF HEPATOCELLULAR CARCINOMA2019

    • Author(s)
      Satoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Kentaro Tanaka, Takeshi Kawasaki, Yoko Yoshimaru, Masakuni Tateyama, Hideaki Naoe, Motohiko Tanaka and Yutaka Sasaki
    • Organizer
      THE LIVER MEETING 2019 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] 進行肝細胞癌に対する集学的なソラフェニブ治療戦略2019

    • Author(s)
      徳永尭之、田中基彦、田中健太郎、楢原哲史、吉丸洋子、川崎剛、長岡克弥、渡邊丈久、立山雅邦、佐々木裕
    • Organizer
      JDDW 2019(第27回 日本消化器関連学会週間)
    • Data Source
      KAKENHI-PROJECT-19K17403
  • [Presentation] Treatment Strategy Based on Sorafenib for Advanced Hepatocellular Carcinoma2018

    • Author(s)
      Takayuki Tokunaga,Motohiko Tanaka,Kentaro Tanaka,Satoshi Narahara,Youko Yoshimaru,Katsuya Nagaoka,Takeshi Kawasaki,Hiroko Setoyama,Takehisa Watanabe,Masakuni Tateyama and Yutaka Sasaki
    • Organizer
      The Liver Meeting 2018 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] Early Prediction of Sorafenib Response in Patients with Hepatocellular Carcinoma: The Possible Role of Secretory Clusterin in Acquired Sorafenib Resistance.2018

    • Author(s)
      Satoshi Narahara,Takehisa Watanabe,Katsuya Nagaoka,Nahoko Fujimoto,Kentaro Tanaka,Takayuki Tokunaga,Takeshi Kawasaki,Youko Yoshimaru,Hiroko Setoyama,Masakuni Tateyama,Hideaki Naoe,Motohiko Tanaka and Yutaka Sasaki
    • Organizer
      The Liver Meeting 2018 - AASLD
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02798
  • [Presentation] Integrative role of histone Iysine demethylase LSD 1/2 in liver cancer metabolism2016

    • Author(s)
      Katsuya Nagaoka , Shinjiro Hino , Akihisa Sakamoto , Jack R Wands , Mitsuyoshi Nakao , Yutaka Sasaki
    • Organizer
      AASLD The Liver Meeting
    • Place of Presentation
      Boston
    • Year and Date
      2016-11-11
    • Data Source
      KAKENHI-PROJECT-25293173
  • [Presentation] エピジェネティクス因子による肝脂質代謝調節~ヒストン修飾酵素LSD2に焦点を当てたNASH・NAFLDの病態解明に向けて~2016

    • Author(s)
      長岡克弥、渡邊丈久、佐々木裕
    • Organizer
      第52回日本肝臓学会総会
    • Place of Presentation
      千葉
    • Year and Date
      2016-05-19
    • Data Source
      KAKENHI-PROJECT-25293173
  • [Presentation] 肝臓の脂質バランス維持におけるヒストンH3K4脱メチル化酵素LSD2の役割:非アルコール性脂肪肝炎の病態解明に向けて2015

    • Author(s)
      長岡克弥、中尾光善、佐々木裕
    • Organizer
      第51回日本肝臓学会総会
    • Place of Presentation
      熊本
    • Year and Date
      2015-05-21
    • Data Source
      KAKENHI-PROJECT-25293173
  • [Presentation] Integrated proteomics analyses identified a phosphoprotein relevant to apoptosis resistance in human hepatocellular carcinoma2015

    • Author(s)
      Naoe H, Hoshida Y, Yokote S, Fujie S, Watanabe T, Nagaoka K, Yamazoe T , Setoyama H, Tanaka M, Fujimoto J, Araki N, Sasaki Y
    • Organizer
      The 65th annual meeting of the American association for the study of liver disease (AASLD2015)
    • Place of Presentation
      San Francisco, USA
    • Year and Date
      2015-11-13
    • Data Source
      KAKENHI-PROJECT-25293173
  • 1.  Sasaki Yutaka (70235282)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 18 results
  • 2.  渡邊 丈久 (20634843)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 20 results
  • 3.  NAKAO MITSUYOSHI (00217663)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 4.  直江 秀昭 (30599246)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 7 results
  • 5.  荒木 令江 (80253722)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 6.  藤元 治朗 (90199373)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 7.  古賀 友紹 (30615092)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  吉村 亮二 (20782569)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  山添 太士 (20736219)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  MASAKI Takahiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 11.  SARUWATARI Junji
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 12.  HINO Shinjiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 13.  古田 陽輝
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  瀬戸山 博子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  鬼木 健太郎
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi